ABMC gains CLIA waiver for Rapid TOX drug tests
This article was originally published in The Gray Sheet
Executive Summary
Kinderhook, N.Y.-based American Bio Medical Corp. says Aug. 27 it expects to see increased sales of the product line now that FDA has granted CLIA-waived status for the point-of-collection drug tests. The waiver includes the 14 drugs ABMC currently tests for, as well as new cut-off levels for its opiate and cocaine tests. While the Rapid TOX line tests for drug traces in urine, the company has other lines that test for drugs in oral fluids